Neoadjuvant therapy
TRAIN 2 Trial: BluePrint predicts response to neoadjuvant pertuzumab in HER2-positive
Breast Cancer Research 25, Article Number: 71 (2023) Authors: Liefaard et al.
Read MoreNeoadjuvant therapy
Breast Cancer Research 25, Article Number: 71 (2023) Authors: Liefaard et al.
Read MorePublication: ASCO 2023, Abstract #521 Authors: Peter D. Beitsch 1 , James V. Pellicane 2 , Lajos Pusztai 3 , Paul L. Baron 4 , Erin F. Cobain 5 , Mary K. Murray 6 , Andrew Ashikari 7 , Pond R. Kelemen 7 , Angela Marie Mislowsky 8 , Julie Barone 9 , Kenneth H. Cowan 10 , Rakhshanda Layeequr Rahman 11 , William C. Dooley 12 , Andrea Menicucci 13 , Christine Carruth 13 , M. William Audeh 13 , Pat W. Whitworth 14 , NBRST Investigators Group
Read MoreSABCS 2022, Poster ID: PD9-08 Authors: Brufsky et al.
Read MorePUBLICATION: San Antonio Breast Cancer Symposium 2022 TITLE: Impact Read More
ASCO 2022, Poster #514 Authors: Kuilman et al.
Read MoreI-SPY2 Trial, Cancer Cell 39, 989–998, 2021 Authors: Pusztai et al.
Read MorePUBLICATION: ASCO 2021 Authors Joyce O’Shaughnessy1, Virginia G. Read More
Publication: St. Gallen Authors: E. Göker, M.P. Hendriks, M. van Read More
Publication: Miami Breast Authors Pat Whitworth, James Read More
PUBLICATION: SABCS 2020 AUTHORS: Peter W. Blumencranz, Mehran Habibi, Read More